04 May 2007
Postprandial plasma lipid levels are influenced by the interaction of functional polymorphisms in the microsome triglyceride transfer protein and beta3 adrenergic receptor genes.
Takahiro Ueno, Yumiko Takahashi, Taro Matsumoto, Akiko Tsunemi, Hideyuki Watanabe, Kazunobu Tahira, Noboru Fukuda, Masayoshi Soma, Koichi MatsumotoMed Sci Monit 2007; 13(5): BR112-118 :: ID: 484563
Abstract
Background: The effects of polymorphisms in the genes encoding microsome triglycerides transfer protein (MTP) and beta3-adrenergic receptor (beta3-AR) on lipid and glucose metabolism were investigated. Material/Methods: Clinical phenotypes related to lipid and glucose metabolism were evaluated during dietary loading (17 g of fat, 750 Cal) and glucose loading (75 g glucose). MTP and beta3-AR genotypes were determined by restriction fragment length polymorphism. Results: Subjects with the Arg64 beta3-AR gene (Arg+) polymorphism showed significantly higher fasting (FTG) and postprandial (PTG) triglyceride levels, fasting plasma glucose (FPG), fasting plasma immuno-reactive insulin (FIRI) and HOMA-R in comparison with Trp64 homozygotes. Subjects with the T allele (T +) of MTP -164T/G polymorphism (with T allele) showed significantly lower levels of FPG, FIRI, HOMA-R and PTG than did subjects without the T allele (T-). To evaluate the interaction of the polymorphisms, we divided our subjects into four groups. T-/Arg-, T-/Arg+, T+/Arg- and T+/Arg+. In these four groups, only T-/Arg+ showed significantly higher PTG levels. Plasma glucose levels were significantly higher at 60 and 120 min after oral glucose loading in in the T-/Arg+ subjects. Conclusions: In this study, we identified an example of genotypic interactions that influence the clinical phenotype in multi-factorial diseases.
Keywords: Carrier Proteins - metabolism, Genotype, Glucose - metabolism, Polymorphism, Genetic, Postprandial Period, Receptors, Adrenergic, beta-3 - metabolism, Triglycerides - blood
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952